Search Results - "Afrasiabi, Ali"

Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression.

Authors: Afrasiabi, Ali Bocking, Wade J. Schibeci, Stephen D. et al.

Source: Immunity, Inflammation & Disease. Mar2026, Vol. 14 Issue 3, p1-5. 5p.

The global prevalence of non-alcoholic fatty liver disease and related terms in adults with inflammatory bowel disease: a systematic review and meta-analysis.

Authors: Musavi, Seyed Mohamad Afrasiabi, Ali

Source: Egyptian Liver Journal. 6/16/2026, Vol. 16 Issue 1, p1-21. 21p.

Safety of Combination TARE and SBRT in Hepatocellular Carcinoma: A Review of Literature & Single-Center Case Series.

Authors: Gholami, Bahareh Afrasiabi, Ali Moon, Andrew M. et al.

Source: Current Oncology. Sep2025, Vol. 32 Issue 9, p487. 10p.

The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.

Authors: Afrasiabi, Ali Alinejad-Rokny, Hamid Khosh, Azad et al.

Source: Scientific Reports. 2/14/2022, Vol. 12 Issue 1, p1-8. 8p.

The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.

Authors: Afrasiabi, Ali Parnell, Grant P. Swaminathan, Sanjay et al.

Source: Scientific Reports. 1/13/2020, Vol. 10 Issue 1, p1-11. 11p.

The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.

Authors: Afrasiabi, Ali Ahlenstiel, Chantelle Swaminathan, Sanjay et al.

Source: Clinical & Translational Immunology. 2023, Vol. 12 Issue 6, p1-10. 10p.

SWEEPS-Assisted Antibacterial Photodynamic Therapy Against Dual-Species Biofilms in Mandibular Molars: An In Vitro Study.

Authors: Guity, Pargol Afrasiabi, Shima Shahi Ardakani, Ali et al.

Source: Pharmaceuticals (14248247). Apr2025, Vol. 18 Issue 4, p558. 16p.

KARAJ: An Efficient Adaptive Multi-Processor Tool to Streamline Genomic and Transcriptomic Sequence Data Acquisition.

Authors: Labani, Mahdieh Beheshti, Amin Lovell, Nigel H. et al.

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 22, p14418. 9p.

Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.

Authors: Afrasiabi, Ali Parnell, Grant P. Fewings, Nicole et al.

Source: Genome Medicine. 4/30/2019, Vol. 11 Issue 1, pN.PAG-N.PAG. 1p.

The Interaction of Human and Epstein–Barr Virus miRNAs with Multiple Sclerosis Risk Loci.

Authors: Afrasiabi, Ali Fewings, Nicole L. Schibeci, Stephen D. et al.

Source: International Journal of Molecular Sciences. Mar2021, Vol. 22 Issue 6, p2927-2927. 1p.